Results 311 to 320 of about 660,625 (335)

The cGAS–STING pathway as a therapeutic target in inflammatory diseases

Nature Reviews Immunology, 2021
Alexiane Decout, Andrea Ablasser
exaly  

Lineage plasticity in cancer: a shared pathway of therapeutic resistance

Nature Reviews Clinical Oncology, 2020
Helena A Yu, Dana Pe'er, Charles L Sawyers   +2 more
exaly  

Classical and alternative pathway of complement in amphibia

Developmental & Comparative Immunology, 1983
B. Hofmanová, V. Dlabač, J. Šimečková, P. Šíma   +3 more
openaire   +2 more sources

Chemical and Biomolecular Strategies for STING Pathway Activation in Cancer Immunotherapy

Chemical Reviews, 2022
Kyle M Garland, Taylor L Sheehy, John T Wilson   +2 more
exaly  

Classical Complement Pathway

2016
Odette Middleton, Helen Wheadon, Alison M. Michie   +2 more
openaire   +1 more source

Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic

Ca-A Cancer Journal for Clinicians, 2011
Timothy A Yap, Johann Sebastian de Bono
exaly  

All change in the prostate cancer diagnostic pathway

Nature Reviews Clinical Oncology, 2020
Derek J Lomas
exaly  

Pathophysiological basis of human papillomavirus in penile cancer: Key to prevention and delivery of more effective therapies

Ca-A Cancer Journal for Clinicians, 2016
Adam S Baumgarten, Anna R Giuliano
exaly  

Recent developments in the medical and surgical treatment of melanoma

Ca-A Cancer Journal for Clinicians, 2014
Jonathan S Zager
exaly  

Complement, Classical Pathway

1998
openaire   +2 more sources